Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2019.1659723 ◽

2019 ◽

Vol 12 (10) ◽

pp. 965-971

Author(s):

Ann C. Childress ◽

Heather Chow

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder

Download Full-text

Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0567-2 ◽

2018 ◽

Vol 34 (12) ◽

pp. 596-596

Author(s):

Katherine A. Lyseng-Williamson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Orally Disintegrating Tablets

Download Full-text

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0065 ◽

2018 ◽

Vol 28 (1) ◽

pp. 29-35 ◽

Author(s):

Carolyn R. Sikes ◽

Russ L. McMahen ◽

Jeffrey G. Stark ◽

Dorothy Engelking

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder

Download Full-text

Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0539-6 ◽

2018 ◽

Vol 34 (9) ◽

pp. 411-419

Author(s):

Katherine A. Lyseng-Williamson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Orally Disintegrating Tablets

Download Full-text

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2018.0078 ◽

2019 ◽

Vol 29 (1) ◽

pp. 2-8 ◽

Author(s):

Ann C. Childress ◽

Judith C. Kando ◽

Thomas R. King ◽

Antonio Pardo ◽

Barry K. Herman

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.366 ◽

2017 ◽

Vol 6 (5) ◽

pp. 476-483

Author(s):

Floyd R. Sallee ◽

Donna R. Palumbo ◽

Richat Abbas ◽

Sally A. Berry ◽

Shivanand P. Puthli ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Food Intake ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Download Full-text

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0095 ◽

2018 ◽

Vol 28 (5) ◽

pp. 306-313 ◽

Author(s):

Ann C. Childress ◽

Sharon B. Wigal ◽

Matthew N. Brams ◽

John M. Turnbow ◽

Yulia Pincus ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists

Integrated Pharmacy Research and Practice ◽

10.2147/iprp.s142576 ◽

2017 ◽

Vol Volume 6 ◽

pp. 163-171 ◽

Author(s):

Joshua Caballero ◽

Edress H Darsey ◽

Faith Walters ◽

Heidi W Belden

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Practical Guide

Download Full-text

NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2012.0073 ◽

2013 ◽

Vol 23 (1) ◽

pp. 3-10 ◽

Author(s):

Sharon B. Wigal ◽

Ann C. Childress ◽

Heidi W. Belden ◽

Sally A. Berry

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Classroom Study

Download Full-text

Effectiveness of an extended release stimulant medication in treating preschool children with attention deficit hyperactivity disorder (The APS Study)

PsycEXTRA Dataset ◽

10.1037/e657832010-001 ◽

2010 ◽

Author(s):

John H. Fanton

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Medication ◽

Hyperactivity Disorder

Download Full-text